Literature DB >> 14993554

Incidence of outpatient visits and hospitalizations related to influenza in infants and young children.

Megan A O'Brien1, Timothy M Uyeki, David K Shay, William W Thompson, Ken Kleinman, Alexander McAdam, Xian-Jie Yu, Richard Platt, Tracy A Lieu.   

Abstract

OBJECTIVE: The Advisory Committee on Immunization Practices currently encourages influenza vaccination for all children aged 6 to 23 months when feasible, based on studies that have demonstrated that young children have high hospitalization rates attributable to influenza. The Advisory Committee on Immunization Practices recently voted to recommend influenza vaccination for all children beginning during the 2004-2005 influenza season; information on the rate of outpatient visits due to influenza is needed to better evaluate the potential health impact and cost-effectiveness of the recommendation. We estimated the incidence of outpatient visits as well as hospitalizations for specific acute respiratory illnesses and for influenza-associated outpatient-visit and hospitalization rates among healthy infants and children in a Massachusetts health maintenance organization. DESIGN/
METHODS: Surveillance data were used to identify when influenza viruses, respiratory syncytial viruses, and parainfluenza viruses were circulating in the greater Boston area during 1994-2000. Using computerized medical records, we identified outpatient visits and hospitalizations for selected respiratory illnesses. Outpatient-visit rates and hospitalizations attributed to influenza were calculated by subtracting the rate of visits during the periseasonal period from the rate of visits during the influenza period. Rates were stratified by age and risk for complications from influenza.
RESULTS: Between 1994 and 2000, there were 188 139 outpatient visits and 885 hospitalizations for respiratory illnesses in the study population. Among healthy children aged 6 to 23 months, the rate per 100 person-months for outpatient visits during influenza periods was 14.5 (95% confidence interval [CI]: 13.9 to 15.1), and the excess rate that could be attributed to influenza compared with the periseasonal period was 1.8 (95% CI: 1.1 to 2.4). Among healthy children, the rate of hospitalizations for acute respiratory disease was 10.4 per 10 000 person-months (95% CI: 6.0 to 17.0), and the rate that could be attributed to influenza when compared with the periseasonal baseline period was 3.9 (95% CI: -2.0 to 0.0). Among children who were at high risk for complications from influenza, the rate of outpatient visits per 100 person-months was 28.7 (95% CI: 26.6 to 30.9) during influenza periods. The rate of hospitalizations among high-risk children was 44.6 per 10 000 person-months (95% CI: 19.0 to 17.0).
CONCLUSION: Influenza season is associated with a substantial increase in outpatient visits by healthy children. These estimates of outpatient visits for influenza will help quantify the potential health benefits and cost savings from influenza vaccination of healthy children aged 6 to 23 months.

Entities:  

Mesh:

Year:  2004        PMID: 14993554     DOI: 10.1542/peds.113.3.585

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  67 in total

1.  Dispelling myths held by parents about the influenza vaccine.

Authors:  N Le Saux
Journal:  Paediatr Child Health       Date:  2009-11       Impact factor: 2.253

Review 2.  Influenza related hospital admissions in children: evidence about the burden keeps growing but the route to policy change remains uncertain.

Authors:  J S Nguyen-Van-Tam
Journal:  Arch Dis Child       Date:  2006-01       Impact factor: 3.791

3.  Pneumococcal and influenza vaccination rates and their determinants in children with chronic medical conditions.

Authors:  Antonietta Giannattasio; Veronica Squeglia; Andrea Lo Vecchio; Maria Teresa Russo; Alessandro Barbarino; Raffaella Carlomagno; Alfredo Guarino
Journal:  Ital J Pediatr       Date:  2010-03-26       Impact factor: 2.638

4.  Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine: a randomized study in US adults.

Authors:  James D Campbell; Christopher V Chambers; Rebecca C Brady; Michael C Caldwell; Nathan L Bennett; Marc A Fourneau; Varsha K Jain; Bruce L Innis
Journal:  Hum Vaccin       Date:  2011-01-01

5.  Influenza vaccination during pregnancy for prevention of influenza confirmed illness in the infants: A systematic review and meta-analysis.

Authors:  Marta C Nunes; Shabir A Madhi
Journal:  Hum Vaccin Immunother       Date:  2017-10-18       Impact factor: 3.452

6.  Automated Screening of Hospitalized Children for Influenza Vaccination.

Authors:  Ari H Pollack; Matthew P Kronman; Chuan Zhou; Danielle M Zerr
Journal:  J Pediatric Infect Dis Soc       Date:  2013-08-06       Impact factor: 3.164

7.  Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system.

Authors:  John S Brownstein; Ken P Kleinman; Kenneth D Mandl
Journal:  Am J Epidemiol       Date:  2005-08-17       Impact factor: 4.897

Review 8.  Targeting the skin for microneedle delivery of influenza vaccine.

Authors:  Dimitrios G Koutsonanos; Richard W Compans; Ioanna Skountzou
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

9.  Influenza-associated cystic fibrosis pulmonary exacerbations.

Authors:  Justin R Ortiz; Kathleen M Neuzil; John C Victor; Anna Wald; Moira L Aitken; Christopher H Goss
Journal:  Chest       Date:  2009-12-04       Impact factor: 9.410

10.  Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial.

Authors:  Byung-Kwang Yoo; Sharon G Humiston; Peter G Szilagyi; Stanley J Schaffer; Christine Long; Maureen Kolasa
Journal:  BMC Health Serv Res       Date:  2015-11-16       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.